Europe Should Pay Drug Prices More In Line With US, Two Pharma CEOs Argue

 
• By Kevin Grogan
  
Paul Hudson and Vas Narasimhan
Paul Hudson (L) and Vas Narasimhan said Europe is penalizing innovation. (Illustration by Kosh Naran)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access